Literature DB >> 3941357

Clinical decision making: dipyridamole thallium imaging.

J B Gill, D D Miller, C A Boucher, H W Strauss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3941357

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  6 in total

1.  A comparison of maximal exercise and dipyridamole thallium-201 planar gated scintigraphy.

Authors:  W Martin; A C Tweddel; G Main; I Hutton
Journal:  Eur J Nucl Med       Date:  1992

2.  Persistent chest pain following oral dipyridamole for thallium 201 myocardial imaging.

Authors:  A H Kwai; A F Jacobson; K M McIntyre; W H Williams; D E Tow
Journal:  Eur J Nucl Med       Date:  1990

Review 3.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

4.  Non-invasive investigation of lower limb revascularisation using resting thallium peripheral perfusion imaging.

Authors:  J J Earnshaw; J G Hardy; B R Hopkinson; G S Makin
Journal:  Eur J Nucl Med       Date:  1986

5.  The Canadian exercise technetium 99m-labeled teboroxime single-photon emission computed tomographic study. Canadian Exercise Teboroxime SPECT Study Investigators.

Authors:  R J Burns; S Iles; A Y Fung; L M Wright; L Daigneault
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

6.  Myocardial 201Tl washout after combined dipyridamole submaximal exercise stress: reference values from different patient groups.

Authors:  L Fridrich
Journal:  Eur J Nucl Med       Date:  1989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.